Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 710 is a member of the zinc finger family of transcription factors characterized by the presence of C2H2-type zinc finger motifs, which enable DNA binding. It is predicted to regulate gene expression by binding to cis-regulatory regions of DNA and acting as a transcriptional regulator, likely in association with RNA polymerase II. ZNF710 is expressed in a variety of tissues and may play a role in diverse cellular processes due to its involvement in gene regulation. No current evidence supports its designation as a conventional therapeutic target such as receptor, enzyme, or transporter, nor has it been directly associated with disease or drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 710 (ZNF710).